Febuxostat Krka (febuxostat) – to treat adults patients with long-term hyperuricaemia (high levels of uric acid or ‘urate’ in the blood)
Febuxostat Krka tablets contain the active substance febuxostat and are used to treat gout, which is associated with an excess of a chemical called uric acid (urate) in the body. In some people, the amount of uric acid builds up in the blood and may become too high to remain soluble. When this happens, urate crystals may form in and around the joints and kidneys. These crystals can cause sudden, severe pain, redness, warmth and swelling in a joint (known as a gout attack). Left untreated, larger deposits called tophi may form in and around joints. These tophi may cause joint and bone damage.
Febuxostat Krka works by reducing uric acid levels. Keeping uric acid levels low by taking Febuxostat Krka once every day stops crystals building up, and over time it reduces symptoms. Keeping uric acid levels sufficiently low for a long enough period can also shrink tophi.
Febuxostat Krka 120 mg tablets are also used to treat and prevent high blood levels of uric acid that may occur when you start to receive hemotherapy for blood cancers.
When chemotherapy is given, cancer cells are destroyed, and uric acid levels increase in the blood accordingly, unless the formation of uric acid is prevented.
Febuxostat Krka is for adults.
NAME OF THE MEDICINAL PRODUCT
Febuxostat Krka 80 mg film-coated tablets
STATEMENT OF ACTIVE SUBSTANCE(S)
Each film-coated tablet contains 80 mg febuxostat.
PHARMACEUTICAL FORM AND CONTENTS
14 film-coated tablets
28 film-coated tablets
56 film-coated tablets
84 film-coated tablets
METHOD AND ROUTE(S) OF ADMINISTRATION